MyFinsight
Home
Blog
About
Back
Income Statement
Mereo BioPharma Group plc (MREO)
Mereo BioPharma Group plc (MREO)
source: myfinsight.com
Total comprehensive
loss
-$6,719,000
(15.69%↑ Y/Y)
Other comprehensive
income/(loss) - foreign...
$286,000
(-95.70%↓ Y/Y)
Net loss
-$7,005,000
(52.07%↑ Y/Y)
Net loss before
income tax
-$7,005,000
(52.07%↑ Y/Y)
Interest income
$278,000
(-52.80%↓ Y/Y)
Benefit from research
and development tax...
$119,000
(-84.03%↓ Y/Y)
Changes in the fair value
of warrants
$6,000
(105.94%↑ Y/Y)
Loss from operations
-$7,030,000
(33.04%↑ Y/Y)
Foreign currency
transaction (loss)/gain,...
-$362,000
(93.20%↑ Y/Y)
Interest expense
$16,000
(-33.33%↓ Y/Y)
General and
administrative
$5,222,000
(-4.95%↓ Y/Y)
Research and development
$1,808,000
(-66.35%↓ Y/Y)
Back